Abstract
Subclinical hypothyroidism (SH) is defined as a serum TSH concentration above the statistically defined upper limit of the reference range when serum free T4 (fT4) concentration is within its reference range [1, 2]. As serum TSH concentration varies over time in healthy subjects, leading to occasional abnormal values, the measurement of serum TSH and fT4 should be repeated within 3–4 months. If elevated serum TSH concentrations are confirmed and fT4 levels are within the normal range, the diagnosis of SH is made. SH is also defined as isolated hyperthyrotropinemia, compensated hypothyroidism, preclinical hypothyroidism, mild thyroid failure, or mild hypothyroidism. The diagnosis of SH is mainly based on a biochemical evaluation because it has been observed that most patients exhibit few or no signs or symptoms of thyroid dysfunction. Many studies suggest that some patients do indeed have clinical or functional manifestations of mild thyroid failure that are more frequent than in age-matched controls [2].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Surks MI, Ortiz E, Daniels GH et al (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228–238
Cooper DS, Biondi B (2012) Subclinical thyroid disease. Lancet 379:1142–1154
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC (2000) The Colorado thyroid disease prevalence study. Arch Intern Med 160:526–534
Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC (1991) Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 34:77–83
Hollowell JG, Staehling NW, Flanders WD et al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499
Vanderpump MP, Tunbridge WM, French JM et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 43:55–69
Paoli-Valeri M, Maman-Alvardo D, Jiménez-Lopez V et al (2003) Frequency of subclinical hypothyroidism among healthy children and those with neurological conditions in the state of Mérida, Venezuela. Invest Clin 44:209–218
Wu T, Flowers JW, Tudiver F, Wilson JL, Punyasavatsut N (2006) Subclinical thyroid disorders and cognitive performance among adolescents in the United States. BMC Pediatr 6:12
Arrigo T, Wasniewska M, Crisafulli G et al (2008) Subclinical hypothyroidism: the state of the art. J Endocrinol Invest 31:79–84
Cooper DS (2001) Clinical practice. Subclinical hypothyroidism. N Engl J Med 345:260–265
Pacifico L, Anania C, Ferraro F, Andreoli GM, Chiesa C (2012) Thyroid function in childhood obesity and metabolic comorbidity. Clin Chim Acta 413:396–405
Reinehr T (2010) Obesity and thyroid function. Mol Cell Endocrinol 316:165–171
Vanderpump MP, Tunbridge WM (2002) Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 12:839–847
Calaciura F, Motta RM, Miscio G et al (2002) Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia. J Clin Endocrinol Metab 87:3209–3214
Leonardi D, Polizzotti N, Carta A et al (2008) Longitudinal study of thyroid function in children with mild hyperthyrotropinemia at neonatal screening for congenital hypothyroidism. J Clin Endocrinol Metab 93:2679–2685
Rapa A, Monzani A, Moia S et al (2009) Subclinical hypothyroidism in children and adolescents: a wide range of clinical, biochemical, and genetic factors involved. J Clin Endocrinol Metab 94:2414–2420
Alberti L, Proverbio MC, Costagliola S et al (2002) Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. J Clin Endocrinol Metab 87:2549–2555
Duprez L, Parma J, Van Sande J et al (1998) TSH receptor mutations and thyroid disease. Trends Endocrinol Metab 9:133–140
Tonacchera M, Di Cosmo C, De Marco G et al (2007) Identification of TSH receptor mutations in three families with resistance to TSH. Clin Endocrinol (Oxf) 67:712–718
Clifton-Bligh RJ, Gregory JW, Ludgate M et al (1997) Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. J Clin Endocrinol Metab 82:1094–1100
Camilot M, Teofoli F, Gandini A et al (2005) Thyrotropin receptor gene mutations and TSH resistance: variable expressivity in the heterozygotes. Clin Endocrinol (Oxf) 63:146–151
De Marco G, Agretti P, Montanelli L et al (2011) Identification and functional analysis of novel dual oxidase 2 (DUOX2) mutations in children with congenital or subclinical hypothyroidism. J Clin Endocrinol Metab 96:E1335–E1339
Grandone A, Perrone L, Cirillo G et al (2012) Impact of phosphodiesterase 8B gene rs4704397 variation on thyroid homeostasis in childhood obesity. Eur J Endocrinol 166:255–260
Peeters RP, van der Deure WM, Visser TJ (2006) Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. Eur J Endocrinol 155:655–662
Turkkahraman D, Alper OM, Aydin F et al (2009) Final diagnosis in children with subclinical hypothyroidism and mutation analysis of the thyroid peroxidase gene (TPO). J Pediatr Endocrinol Metab 22:845–851
Aijaz NJ, Flaherty EM, Preston T et al (2006) Neurocognitive function in children with compensated hypothyroidism: lack of short term effects on or off thyroxin. BMC Endocr Disord 6:2
Monzani A, Prodam F, Rapa A et al (2012) Endocrine disorders in childhood and adolescence. Natural history of subclinical hypothyroidism in children and adolescents and potential effects of replacement therapy: a review. Eur J Endocrinol 168:R1–R11
Cerbone M, Bravaccio C, Capalbo D et al (2011) Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur J Endocrinol 164:591–597
Marcocci C, Vitti P, Cetani F et al (1991) Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab 72:209–213
Bona G, Prodam F, Monzani A (2013) Subclinical hypothyroidism in children: natural history and when to treat. J Clin Res Pediatr Endocrinol 5:23–28
Gopalakrishnan S, Chugh PK, Chhillar M et al (2008) Goitrous autoimmune thyroiditis in a pediatric population: a longitudinal study. Pediatrics 122:670–674
Zois C, Stavrou I, Svarna E, Seferiadis K, Tsatsoulis A (2006) Natural course of autoimmune thyroiditis after elimination of iodine deficiency in northwestern Greece. Thyroid 16:289–293
Radetti G, Gottardi E, Bona G et al (2006) The natural history of euthyroid Hashimoto’s thyroiditis in children. J Pediatr 149:827–832
Wasniewska M, Salerno M, Cassio A et al (2009) Prospective evaluation of the natural course of idiopathic subclinical hypothyroidism in childhood and adolescence. Eur J Endocrinol 160:417–421
Moore DC (1996) Natural course of ‘subclinical’ hypothyroidism in childhood and adolescence. Arch Pediatr Adolesc Med 150:293–297
Jaruratanasirikul S, Leethanaporn K, Khuntigij P, Sriplung H (2001) The clinical course of Hashimoto’s thyroiditis in children and adolescents: 6 years longitudinal follow-up. J Pediatr Endocrinol Metab 14:177–184
Lazar L, Frumkin RB, Battat E et al (2009) Natural history of thyroid function tests over 5 years in a large pediatric cohort. J Clin Endocrinol Metab 94:1678–1682
Radetti G, Maselli M, Buzi F et al (2012) The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto’s thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up. Clin Endocrinol 76:394–398
Aversa T, Valenzise M, Corrias A et al (2015) Underlying Hashimoto’s thyroiditis negatively affects the evolution of subclinical hypothyroidism in children irrespective of other concomitant risk factors. Thyroid 25:183–187
Althaus BU, Staub JJ, Ryff-De Leche A, Oberhansli A, Stahelin HB (1988) LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol 28:157–163
Nanchen D, Gussekloo J, Westendorp RG et al (2012) Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab 97:852–861
Hak AE, Pols HA, Visser TJ et al (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132:270–278
Rodondi N, den Elzen WP, Bauer DC et al (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365–1374
Haggerty JJ Jr, Stern RA, Mason GA et al (1993) Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry 150:508–510
Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM (1995) Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med 155:1490–1495
Staub JJ, Althaus BU, Engler H et al (1992) Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 92:631–642
Muller B, Tsakiris DA, Roth CB et al (2001) Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur J Clin Invest 31:131–137
Faber J, Galloe AM (1994) Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 130:350–356
Sawin CT, Geller A, Wolf PA et al (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249–1252
Atzmon G, Barzilai N, Hollowell JG, Surks MI, Gabriely I (2009) Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 94:1251–1254
Rozing MP, Houwing-Duistermaat JJ, Slagboom PE et al (2010) Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab 95:4979–4984
Gharib H, Tuttle RM, Baskin HJ et al (2005) Consensus statement: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association and the Endocrine Society. J Clin Endocrinol Metab 90:581–585
Cetinkaya E, Aslan A, Vidinlisan S, Ocal G (2003) Height improvement by L-thyroxine treatment in subclinical hypothyroidism. Pediatr Int 45:534–537
Chase HP, Garg SK, Cockerham RS, Wilcox WD, Walravens PA (1990) Thyroid hormone replacement and growth of children with subclinical hypothyroidism and diabetes. Diabet Med 7:299–303
Svensson J, Ericsson UB, Nilsson P et al (2006) Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J Clin Endocrinol Metab 91:1729–1734
Johner SA, Thamm M, Stehle P et al (2014) Interrelations between thyrotropin levels and iodine status in thyroid-healthy children. Thyroid 24:1071–1079
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Monzani, A., Prodam, F., Bellone, S., Bona, G. (2015). Subclinical Hypothyroidism. In: Bona, G., De Luca, F., Monzani, A. (eds) Thyroid Diseases in Childhood. Springer, Cham. https://doi.org/10.1007/978-3-319-19213-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-19213-0_17
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19212-3
Online ISBN: 978-3-319-19213-0
eBook Packages: MedicineMedicine (R0)